You searched for "reinnervation"

3104 results found

FENTEX Medical welcomes Michael Voegtle as Director of International Sales

Michael Voegtle has joined the Team of FENTEX medical as the new Director of International Sales. Michael has a long and successful track record in the medical industry.

ENT UK welcomes Amanda Stratford as new CEO

We are delighted to introduce Amanda Stratford as the new CEO of ENT UK. Amanda, who took over from Katie Nurcombe as CEO on 2 January, comes from a health charity and NHS background, with 20 years of charity sector...

Lenire tinnitus treatment device now available in Canada

The Lenire® tinnitus treatment device is now available in Canada through 21 clinics across Alberta, British Colombia, Manitoba, Ontarioand Québec. Forty-three percent of Canadians (11.2 million) report experiencing tinnitus in their lifetime, with 37% (9.2 million) experiencing tinnitus in the...

Bevacizumab, NF2, hearing and age

Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....

Determinants influencing ageing within the vestibular system

The observation that ageing affects vestibular function is not new. However, using a whole population survey, the authors set out to evaluate quantitatively factors responsible for the age-related changes in vestibular function. As part of a national survey on health...

Current perspectives of tinnitus and its management

Whilst there are various therapeutic options for ameliorating the impact of tinnitus, there is no current approved treatment for attempting to eradicate, or even for reducing, the loudness of tinnitus.

Patient-centred and accelerating progress: two organisations changing the landscape for rare skull base tumours

Patient-led organisations are transforming care for rare skull base tumours by connecting patients, clinicians and researchers to accelerate diagnosis, support and scientific progress. A skull base tumour diagnosis is a difficult time for any patient, but it is made more...

Ear, Nose and Throat 2024

Liza Delfin, Non-Medical Prescriber/RCN Leadership Graduate, Advance Nurse Practitioner, Ear, Nose and Throat Department, Guys and St Thomas Hospital, London, UK. Experts from around the world converged at the 11th National Ear, Nose and Throat 2024 conference where distinguished surgeons...

Pioneering standards of aural care in the UK: vision and initiatives of the NACSG

Ear wax removal remains a controversial subject in the UK. How will a strategy group support reform in the sector? Background: elevating standards in aural care The National Aural Care Strategy Group (NACSG) was established to address the multifaceted challenges...

Hearing loss and dementia – a webinar with Professor Kevin Munro

Transforming the narrative around hearing loss and dementia A webinar with Professor Kevin Munro The British and Irish Hearing Instrument Manufacturers Association (BIHIMA) and Professor Kevin Munro, a leading expert in audiology, will host a webinar to discuss the critical...

The future of rhinology: What will come first, a radical change in rhinological management or the decimation of the world?

In this article, Simon Gane looks forward to what the future holds, on the presumption he survives. Setting aside the questions of the UK even existing, the NHS still working, or the fact we’ll be commuting to our jobs in...

Selecting and optimising hearing aids for tinnitus benefit: a rough guide

Hearing aids have a relatively long history as tinnitus treatment tools. Saltzman and Ersner reported success in suppressing tinnitus with simple hearing aids in a number of cases as early as 1947 [1]. In an early comprehensive approach to tinnitus...